Both in Pharmaceuticals
Kailera Therapeutics vs Ocular Therapeutix
Over the past year KLRA returned −9.8% and OCUL returned −35.0%; their daily moves had a correlation of 0.34.
KLRA −9.8% OCUL −35.0%Growth of $1, one year, split-adjusted
| Metric | KLRA | OCUL |
|---|---|---|
| Price | $12.58 | $6.82 |
| Market cap | $1.63B | $1.50B |
| Today | +3.54% | +1.34% |
| 1 month | +16.1% | −5.9% |
| 6 months | — | −29.8% |
| Year to date | — | −43.8% |
| 1 year | — | −41.5% |
| Revenue growth (YoY) | — | +0.1% |
| Gross margin | — | 85.1% |
| Net margin | — | −584.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 28.8× |
| Net cash | $916.7M | $525.8M |
| Dividend yield | — | — |
| Volatility (60d) | — | 75.6% |
| Short % of float | 9.1% | 15.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).